Literature DB >> 10880337

Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA.

L Zheng1, L Yu, Q Tu, M Zhang, H He, W Chen, J Gao, J Yu, Q Wu, S Zhao.   

Abstract

Two novel members of the human cAMP-dependent protein kinase inhibitor (PKI) gene family, PKIB and PKIG, were cloned. The deduced proteins showed 70% and 90% identity with mouse PKIbeta and PKIgamma respectively. Both the already identified pseudosubstrate site and leucine-rich nuclear export signal motifs were defined from the 11 PKIs of different species. The PKIB and PKIG genes were mapped respectively to chromosome 6q21-22.1, using a radiation hybrid GB4 panel, and to chromosome 20q13.12-13.13, using a Stanford G3 panel. Northern-blot analysis of three PKI isoforms, including the PKIA identified previously, revealed significant differences in their expression patterns. PKIB had two transcripts of 1.9 kb and 1.4 kb. The former transcript was abundant in both placenta and brain and the latter was expressed most abundantly in placenta, highly in brain, heart, liver, pancreas, moderately in kidney, skeletal muscle and colon, and very little in the other eight tissues tested. PKIG was widely expressed as a 1.5-kb transcript with the highest level in heart, hardly detectable in thymus and peripheral blood leucocytes and was moderately expressed in the other tissues, with slightly different levels. However, PKIA was specifically expressed as two transcripts of 3.3 kb and 1.5 kb in heart and skeletal muscle. The distinct expression patterns of the three PKIs suggest that their roles in various tissues are probably different.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880337      PMCID: PMC1221161          DOI: 10.1042/0264-6021:3490403

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase.

Authors:  S R Olsen; M D Uhler
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse.

Authors:  M A Scarpetta; M D Uhler
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

Review 3.  Structure, function, and regulation of human cAMP-dependent protein kinases.

Authors:  K Taskén; B S Skålhegg; K A Taskén; R Solberg; H K Knutsen; F O Levy; M Sandberg; S Orstavik; T Larsen; A K Johansen; T Vang; H P Schrader; N T Reinton; K M Torgersen; V Hansson; T Jahnsen
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1997

4.  Characterization of PKIgamma, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase.

Authors:  S P Collins; M D Uhler
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

5.  Fitting a mixture model by expectation maximization to discover motifs in biopolymers.

Authors:  T L Bailey; C Elkan
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1994

6.  Identification of a signal for rapid export of proteins from the nucleus.

Authors:  W Wen; J L Meinkoth; R Y Tsien; S S Taylor
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

7.  Isoform-specific differences in the potencies of murine protein kinase inhibitors are due to nonconserved amino-terminal residues.

Authors:  D M Gamm; M D Uhler
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

8.  Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein.

Authors:  D B Glass; H C Cheng; L Mende-Mueller; J Reed; D A Walsh
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

9.  Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor.

Authors:  S R Olsen; M D Uhler
Journal:  Mol Endocrinol       Date:  1991-09

10.  Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.

Authors:  J D Scott; M B Glaccum; E H Fischer; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  10 in total

1.  Structure characterization of human RalGDS gene, and the identification of its novel variant.

Authors:  Q Zheng; L Yu; Y Zhao; H Zhang; Q Fu; N Mao; P Hu; Z Geng; S Zhao
Journal:  Mol Biol Rep       Date:  2000       Impact factor: 2.316

2.  Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor.

Authors:  Paloma H Giangrande; Timothy C Hallstrom; Chainarong Tunyaplin; Kathryn Calame; Joseph R Nevins
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

3.  Ascl1-induced neuronal differentiation of P19 cells requires expression of a specific inhibitor protein of cyclic AMP-dependent protein kinase.

Authors:  Holly S Huang; David L Turner; Robert C Thompson; Michael D Uhler
Journal:  J Neurochem       Date:  2011-06-24       Impact factor: 5.372

4.  Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase.

Authors:  L Spicuzza; M G Belvisi; M A Birrell; P J Barnes; D J Hele; M A Giembycz
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  G-patch domain and KOW motifs-containing protein, GPKOW; a nuclear RNA-binding protein regulated by protein kinase A.

Authors:  Anne Kristin Aksaas; Anja Cv Larsen; Marie Rogne; Ken Rosendal; Anne-Katrine Kvissel; Bjørn Steen Skålhegg
Journal:  J Mol Signal       Date:  2011-08-31

6.  Alterations of gene profiles in Leydig-cell-regenerating adult rat testis after ethane dimethane sulfonate-treatment.

Authors:  Yu-Fei Zhang; Kai-Ming Yuan; Yong Liang; Yan-Hui Chu; Qing-Quan Lian; Yu-Fei Ge; Wei Zhen; Chantal M Sottas; Zhi-Jian Su; Ren-Shan Ge
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

Review 7.  Protein Kinase Inhibitor Peptide as a Tool to Specifically Inhibit Protein Kinase A.

Authors:  Chong Liu; Ping Ke; Jingjing Zhang; Xiaoying Zhang; Xiongwen Chen
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

8.  Quantitative trait loci affecting atherosclerosis at the aortic root identified in an intercross between DBA2J and 129S6 apolipoprotein E-null mice.

Authors:  Yukako Kayashima; Hirofumi Tomita; Svetlana Zhilicheva; Shinja Kim; Hyung-Suk Kim; Brian J Bennett; Nobuyo Maeda
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

9.  An in cellulo-derived structure of PAK4 in complex with its inhibitor Inka1.

Authors:  Yohendran Baskaran; Khay C Ang; Praju V Anekal; Wee L Chan; Jonathan M Grimes; Ed Manser; Robert C Robinson
Journal:  Nat Commun       Date:  2015-11-26       Impact factor: 14.919

10.  Downregulation of cAMP-Dependent Protein Kinase Inhibitor-b Promotes Preeclampsia by Decreasing Phosphorylated Akt.

Authors:  Chunfeng Liu; Hao Wang; Mo Yang; Yiheng Liang; Li Jiang; Siman Sun; Shangrong Fan
Journal:  Reprod Sci       Date:  2020-07-16       Impact factor: 3.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.